Venöz Trombozis ve D Vitamini
Özet
D vitamini, kalsiyum-fosfor metabolizmasının yanı sıra vücutta 200'den fazla genin ekspresyonunu kontrol eden ve bağışıklık ile kardiyovasküler sistemler üzerinde önemli rolleri olan yağda çözünen bir vitamindir. Son yıllarda yapılan çalışmalar, D vitamini eksikliği ile venöz tromboz (dolaşım sisteminde kanın pıhtılaşması) arasında önemli bir ilişki olduğunu ortaya koymaktadır. Tromboz vakalarının kış aylarında artması ve derin ven trombozu olan hastalarda D vitamini seviyelerinin belirgin şekilde düşük saptanması bu ilişkiyi desteklemektedir. D vitamini; doku faktörünü azaltarak, trombomodulini artırarak ve inflamatuar sitokinlerin salınımını baskılayarak antitrombotik etki gösterir, böylece damar endotel bütünlüğünü korur. Eksikliği durumunda ise insülin direnci, oksidatif stres ve inflamasyon gibi mekanizmalar tetiklenerek pıhtılaşma riski artar. Özellikle venöz tromboz riski taşıyan bireylerde D vitamini replasman tedavisi (sabah saatlerinde ve yüksek dozda) pıhtı riskini azaltmada etkilidir. Sentetik takviyeler yerine güneş ışığı maruziyeti ve Akdeniz diyeti gibi doğal yollarla D vitamini düzeylerinin artırılması önerilmektedir.
Vitamin D is a fat-soluble vitamin that regulates calcium-phosphorus metabolism and controls the expression of more than 200 genes, playing significant roles in the immune and cardiovascular systems. Recent studies demonstrate a strong correlation between vitamin D deficiency and venous thrombosis, which is characterized by blood clotting within the circulatory system. This relationship is supported by the increased incidence of thrombotic events during winter months and the remarkably low vitamin D levels observed in deep vein thrombosis patients. Vitamin D exerts antithrombotic effects by decreasing tissue factor, increasing thrombomodulin, and suppressing the release of inflammatory cytokines, thereby maintaining vascular endothelial integrity. Conversely, its deficiency triggers mechanisms such as insulin resistance, oxidative stress, and inflammation, which elevate the risk of clotting. Vitamin D replacement therapy, particularly administered in high doses during morning hours, is effective in mitigating clot risks for individuals predisposed to venous thrombosis. Rather than relying solely on synthetic supplements, increasing vitamin D levels through natural means, such as enhanced sun exposure and a Mediterranean diet, is highly recommended.
Referanslar
Genç A, Sevim DG, Özen AT, Yılmaz G. D vitamininin çeşitli hastalıklardaki nadir kullanım alanları. Ankara Tıp Üniversitesi Fakültesi Mecmuası 2015; 68: 55-60.
Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr. Rev. 2005; 26:662–87.
Uwitonze AM, Razzaque MS. Role of magnesium in vitamin D activation and function. J Am Osteopath Assoc 2018; 118: 181-9.
Mohammad S, Mishra A, Ashraf MZ. Emerging Role of Vitamin D and its Associated Molecules in Pathways Related to Pathogenesis of Thrombosis. Biomolecules 2019; 9: 649-63.
Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev. 2009; 23: 225–9.
Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003; 348:1435–41.
Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation. 2010; 121:1896–903.
Akar N, Yılmaz E, Akar E, et al. Effect of plasminogen activator inhibtor-1 4G/5G polymorphism in Turkish deep vein thrombosis patients with and without FV 1691 G-A. Thromb Res 2000; 97: 227-30.
Mascitelli L, Grant WB, Goldstein MR. The role of hypovitaminosis D in pregnancy-related venous thromboembolism. Int J Clin Pract 2013; 67: 97.
Hejazi ME, Modarresi-Ghazani F, Hamishehkar H, et al. The Effect of Treatment of Vitamin D Deficiency on the Level of P-Selectin and hs-CRP in Patients With Thromboembolism: A Pilot Randomized Clinical Trial. J Clin Pharmacol 2017; 57: 40-7.
Ekim M, Ekim H. D Vitamini Eksikliğiyle Derin Ven Trombozu Arasındaki İlişki. Van Tıp Derg 2019; 26: 526-31.
Lindqvist PG, Epstein E, Olsson H. Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis. J Thromb Haemost 2009; 7: 605-10.
Brondum-Jacobsen P, Benn M, Tybjaerg-Hansen A, Nordestgaard BG. 25-Hydroxyvitamin D concentrations and risk of venous thromboembolism in the general population with 18791 participants. J Thromb Haemost. 2013; 11:423–31.
Brodin E, Lerstad G, Grimnes G, et al. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromso Study. Thromb Haemost. 2013; 109:885–90.
Artaza JN, Mehrotra R, Norris KC. Vitamin D and the Cardiovascular System. Clin J Am Soc Nephrol 2009; 4:1515–22.
Gupta N, Sahu A, Prabhakar A, et al. Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia. Proc. Natl. Acad. Sci. 2017; 114:4763–8.
Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009; 19:73–8.
Blondon M, Rodabough RJ, Budrys N, et al. The Effect of Calcium plus vitamin D supplementation on the risk of venous thromboembolism in the Women’s Health Initiative Randomized Controlled Trial. Thromb Haemost 2015; 113:999-1009.
Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009; 169:626–32.
Grant WB. Higher rates of venous thromboembolism for Black-Americans are likely due to lower serum 25-hydroxyvitamin D levels. Am J Hematol. 2010; 85:907.
Powe CE, Evans MK, Wenger J, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369:1991–2000.
Folsom AR, Roetker NS, Rosamond WD, et al. Serum 25-hydroxyvitamin D and risk of venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost. 2014; 12: 1455–60.
Wu-Wong JR. Are vitamin D receptor activators useful for the treatment of thrombosis? Curr Opin Investig Drugs. 2009; 10: 919-27.
Piantoni S, Andreoli L, Allegri F, et al. Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease. Reumatismo. 2012; 64: 307-13.
Moscarelli L, Zanazzi M, Bertoni E, et al. Renin angiotensin system blockade and activated vitamin D as a means of preventing deep vein thrombosis in renal transplant recipients. Clin Nephrol. 2011; 75:440–50.
Beer TM, Venner PM, Ryan CW, et al. High dose calcitriol may reduce thrombosis in cancer patients. Br J Haematol. 2006; 135:392–4.
Koyama T and Hirosawa S. Anticoagulant effects of synthetic retinoids and activated vitamin D3. Semin. Thromb. Hemost. 1998; 24: 217-26.
Ohsawa M, Koyama T, Yamamoto K, et al. 1-Alpha, 25-dihydroxyvitamin D3 and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 2000; 102: 2867-72.
Michel G, Gailis A, Jarzebska-Deussen B, et al. 1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells. Inflamm. Res. 1997; 46: 32-4.
Molinari C, Uberti F, Grossini E, et al. 1,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem. 2011; 27: 661–8.
Entezari-Maleki T, Talasaz AH, Salarifar M, et al. Plasma Vitamin D Status and Its Correlation with Risk Factors of Thrombosis, P-selectin and hs-CRP Level in Patients with Venous Thromboembolism; the First Study of Iranian Population. Iran J Pharm Res. 2014; 13:319-27.
Targher G, Pichiri I, Lippi G. Vitamin D, thrombosis, and hemostasis: more than skin deep. Semin Thromb Hemost. 2012; 38:114–24.
Schardey J, Globig AM, Janssen C, et al. Vitamin D inhibits pro-inflammatory T cell function in patients with inflammatory bowel disease. J Crohns Colitis 2019; 13:1546-57.
Khademvatani K, Seyyed-Mohammadzad MH, Akbari M, et al. The relationship between vitamin D status and idiopathic lower-extremity deep vein thrombosis. Int J Gen Med 2014:7 303-9.
Wu WX, He DR. Low Vitamin D Levels Are Associated With the Development of Deep Venous Thromboembolic Events in Patients With Ischemic Stroke Clin Appl Thromb Hemost 2018; 24:69-75.
Vučković BA, van Rein N, Cannegieter SC, et al. Vitamin supplementation on the risk of venous thrombosis: results from the MEGA case-control study. Am J Clin Nutr 2015; 101: 606-12.
Steffen LM, Folsom AR, Cushman M, et al. Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Circulation 2007; 115: 188-95.
